The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s injectable drug delivery devices market report forecasts the injectable drug delivery devices market size to grow to $58.1 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Injectable Drug Delivery Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Injectable Drug Delivery Devices Market Size Forecast
The global injectable drug delivery devices market is expected to grow from $39.93 billion in 2022 to $43.54 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global injectable drug delivery devices market size is expected to grow from $58.1 billion in 2027 at a CAGR of 7.5%.

North America held the largest injectable drug delivery devices market share.

Key Injectable Drug Delivery Devices Market Driver ­– Increase In The Preference For Self-Injection Devices
Self-injection devices include needle-free, auto, pen, and wearable injectors. These self-injectables were developed to provide the most adaptable device which has a high precision of drug delivery and is easy to use. In addition, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years. BD Physioject is a disposable auto-injector, manufactured by Becton, Dickinson, and Company, which is clinically proven, reliable, and cost-effective specifically designed for self-injection of drugs by patients suffering from chronic diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. The other companies currently involved in the self-injections market include Abbvie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., and more. The advantages of self-injectable injections and increasing awareness of self-administration have increased the demand for self-injectable devices and will drive the injectable drug delivery devices market during the forecast period.

Request for A Sample Of The Global Injectable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

Key Injectable Drug Delivery Devices Market Trend – Manufacturing Of Auto-Injectors
The companies in injectable drug delivery devices are increasingly focusing on the manufacturing of auto-injectors. The auto-injectors are fully automated, highly customized, and reusable injectors that can be used by a patient to perform hundreds of injections. Patients can control the speed of dose delivery to help minimize pain or discomfort during injection. These devices can adjust the speed and depth of the automatic injection. For instance, LISA, a reusable auto-injector manufactured by Unilife corporation comes with an array of highly customizable features including Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming for target therapies. The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches to improve the convenience and ease of administration of parenteral therapeutics.

Injectable Drug Delivery Devices Market Segment
1) By Type: Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End User: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users

Injectable Drug Delivery Devices Market Major Players and Strategies
Major players in the injectable drug delivery devices market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi.

The Injectable Drug Delivery Devices Global Market Report 2023 covers regional data on injectable drug delivery devices market size, injectable drug delivery devices market trends and drivers, opportunities, strategies, and injectable drug delivery devices market competitor analysis. The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Injectable drug delivery devices are used for various routes of drug administration such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular.

View More Reports Related To The Injectable Drug Delivery Devices Market –
Implantable Drug Delivery Devices Global Market Report 2023
Liposomal Drug Delivery Devices Global Market Report 2023
Drug Delivery Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

 Found this article helpful? Share it on: